Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Novartis
Express Scripts
US Department of Justice
Queensland Health
Harvard Business School
Daiichi Sankyo
Citi
Colorcon

Generated: October 19, 2017

DrugPatentWatch Database Preview

LAC-HYDRIN Drug Profile

« Back to Dashboard

Which patents cover Lac-hydrin, and what generic Lac-hydrin alternatives are available?

Lac-hydrin is a drug marketed by Ranbaxy and is included in two NDAs.

The generic ingredient in LAC-HYDRIN is ammonium lactate. There are thirty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ammonium lactate profile page.

Summary for Tradename: LAC-HYDRIN

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list14
Clinical Trials: see list13
Patent Applications: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LAC-HYDRIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy
LAC-HYDRIN
ammonium lactate
CREAM;TOPICAL020508-001Aug 29, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy
LAC-HYDRIN
ammonium lactate
LOTION;TOPICAL019155-001Apr 24, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LAC-HYDRIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ranbaxy
LAC-HYDRIN
ammonium lactate
LOTION;TOPICAL019155-001Apr 24, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Novartis
Chubb
Boehringer Ingelheim
Dow
AstraZeneca
Federal Trade Commission
Farmers Insurance
Healthtrust
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot